Wolverine Trading’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $68.4K | Sell |
10,777
-2,539
| -19% | -$16.1K | ﹤0.01% | 1106 |
|
2025
Q1 | $62.1K | Buy |
+13,316
| New | +$62.1K | ﹤0.01% | 1188 |
|
2024
Q4 | – | Sell |
-22,117
| Closed | -$166K | – | 1783 |
|
2024
Q3 | $166K | Buy |
+22,117
| New | +$166K | ﹤0.01% | 1118 |
|
2024
Q2 | – | Hold |
0
| – | – | – | 1520 |
|
2024
Q1 | – | Hold |
0
| – | – | – | 1479 |
|
2023
Q4 | – | Sell |
-23,915
| Closed | -$81.3K | – | 1527 |
|
2023
Q3 | $81.3K | Buy |
23,915
+11,499
| +93% | +$39.1K | ﹤0.01% | 1018 |
|
2023
Q2 | $94.6K | Buy |
+12,416
| New | +$94.6K | ﹤0.01% | 930 |
|
2023
Q1 | – | Hold |
0
| – | – | – | 1377 |
|
2022
Q4 | – | Hold |
0
| – | – | – | 1337 |
|
2022
Q3 | – | Hold |
0
| – | – | – | 1514 |
|
2022
Q2 | – | Hold |
0
| – | – | – | 1498 |
|
2022
Q1 | – | Sell |
-9,182
| Closed | -$414K | – | 1801 |
|
2021
Q4 | $414K | Buy |
9,182
+5,320
| +138% | +$240K | ﹤0.01% | 950 |
|
2021
Q3 | $200K | Buy |
3,862
+541
| +16% | +$28K | ﹤0.01% | 1568 |
|
2021
Q2 | $213K | Buy |
3,321
+726
| +28% | +$46.6K | ﹤0.01% | 1446 |
|
2021
Q1 | $234K | Sell |
2,595
-8,150
| -76% | -$735K | ﹤0.01% | 1394 |
|
2020
Q4 | $996K | Buy |
+10,745
| New | +$996K | ﹤0.01% | 525 |
|
2020
Q3 | – | Hold |
0
| – | – | – | 1451 |
|
2019
Q2 | – | Sell |
-13,065
| Closed | -$660K | – | 1409 |
|
2019
Q1 | $660K | Buy |
+13,065
| New | +$660K | ﹤0.01% | 488 |
|
2018
Q4 | – | Hold |
0
| – | – | – | 1489 |
|
2018
Q3 | – | Sell |
-8,463
| Closed | -$446K | – | 1693 |
|
2018
Q2 | $446K | Hold |
8,463
| – | – | ﹤0.01% | 741 |
|
2018
Q1 | $446K | Buy |
+8,463
| New | +$446K | ﹤0.01% | 741 |
|
2017
Q3 | – | Sell |
-7,410
| Closed | -$249K | – | 1440 |
|
2017
Q2 | $249K | Buy |
+7,410
| New | +$249K | ﹤0.01% | 916 |
|
2017
Q1 | – | Hold |
0
| – | – | – | 1437 |
|
2016
Q3 | – | Sell |
-13,069
| Closed | -$368K | – | 1341 |
|
2016
Q2 | $368K | Buy |
+13,069
| New | +$368K | ﹤0.01% | 481 |
|